114 drugs pass bioequivalence testing in first half

Published: 2011-07-18 06:59:00

Updated: 2011-07-18 06:59:00

The Korea Food and Drug Administration said Thursday that it approved a total of 114 bioequivalence-endorsed medicines in the first half of this year, down 35 percent compared with 176 drugs in the same period of last year.

By active ingredient, pregabalin led any others with 20 cases, followe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK